Related Experiment Videos
Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4
Matthew R Young1, Hsin-Sheng Yang, Nancy H Colburn
1The Gene Regulation Section, Basic Research Laboratory, National Cancer Institute - Frederick, National Institutes of Health, Frederick, MD 21702, USA. youngm@ncifcrf.gov
Abstract:
There are still many unanswered questions regarding the processes by which extracellular signals are transduced from plasma-membrane receptors to the transcription machinery in the nucleus and the translation machinery in the cytoplasm. Some of these gene expression events become misregulated as a result of environmental or endogenous exposure to agents that cause multistage carcinogenesis. We are now beginning to identify and validate the crucial molecular events that drive the rate-limiting steps of carcinogenesis and to target these events for cancer prevention. Transcription factors AP-1 and nuclear factor kappa B can be specifically targeted to prevent cancer induction in mouse models. A protein known as programmed-cell-death-4 is a new potential molecular target that has a surprising mode of action.
Insights
Understanding how cells process external signals is key to preventing cancer. Targeting specific pathways like AP-1 and NF-kappa B, and exploring proteins like programmed-cell-death-4, offers new cancer prevention strategies.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Extracellular signal transduction pathways from plasma-membrane receptors to nuclear and cytoplasmic machinery remain incompletely understood.
- Dysregulation of gene expression during these processes is implicated in multistage carcinogenesis.
- Identifying rate-limiting steps in carcinogenesis is crucial for developing targeted cancer prevention strategies.
Purpose of the Study:
- To elucidate the molecular mechanisms of signal transduction in gene expression.
- To identify and validate key molecular events driving carcinogenesis.
- To explore novel molecular targets for cancer prevention.
Main Methods:
- Investigated signal transduction pathways.
- Validated molecular events in carcinogenesis.
- Utilized mouse models for cancer induction studies.
- Examined transcription factors AP-1 and nuclear factor kappa B.
- Assessed the role of programmed-cell-death-4.
Main Results:
- Demonstrated that transcription factors AP-1 and nuclear factor kappa B can be specifically targeted to prevent cancer induction in mouse models.
- Identified programmed-cell-death-4 as a novel molecular target with a unique mechanism of action.
Conclusions:
- Targeting specific molecular pathways, such as those involving AP-1 and NF-kappa B, shows promise for cancer prevention.
- Programmed-cell-death-4 represents a new and intriguing target for therapeutic intervention in cancer.